![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 6, 2773-2778, Feb, 1988
DO Stene and RC Murphy
Little is known about the metabolic fate of the sulfidopeptide leukotrienes
(LTC4/D4/E4). Earlier studies using radiolabeled leukotrienes have shown
that these potent molecules are concentrated and metabolized in the liver
when administered to mice and that isolated rat hepatocytes have a high
affinity uptake system for LTE4. N- Acetyl-LTE4 has been identified as a
metabolite of LTC4 in the bile of rats, but the majority of the metabolites
in these studies were not characterized. Based on these earlier reports,
incubation of LTE4 with isolated rat hepatocytes was chosen as a model for
the study of sulfidopeptide leukotriene metabolism. [3H]LTE4 was incubated
with isolated rat hepatocytes and the metabolites formed were purified
extensively by ODS flash column chromatography, TLC, and reverse phase-
high pressure liquid chromatography. Metabolites were identified by
retention of the radiolabel and UV absorbance at 280 nm. Purified
metabolites were characterized by UV spectroscopy, fast atom bombardment
mass spectrometry, negative ion chemical ionization gas chromatography-mass
spectrometry, and electron impact gas chromatography-mass spectrometry. Six
LTE4 hepatocyte metabolites were characterized. Metabolite A was determined
to be N-acetyl-LTE4. Metabolite B was determined to be the omega-oxidation
product 20- carboxy-N-acetyl-LTE4. Metabolite C was characterized as the
beta- oxidation product 18-carboxydinor-N-acetyl-LTE4. A further round of
beta-oxidation with a concomitant double bond reduction produced Metabolite
D, identified as 16-carboxytetranordihydro-N-acetyl-LTE4. The reduction of
the 14-15 double bond was most likely the result of the action of
2,4-dienoyl-CoA reductase. The UV spectrum of Metabolite E indicated the
presence of a conjugated tetraene, and this metabolite was determined to be
16-carboxytetranor-delta 13-N-acetyl-LTE4. Metabolite F was identified as
14-carboxyhexanor-N-acetyl-LTE4. The observed pathway of beta-oxidation of
LTE4 proceeded entirely from the C-20 methyl terminus after omega-oxidation
which is in contrast to the known metabolic fate of other eicosanoids. This
may be due to the failure to generate the required thioester at C-1 in LTE4
through a strong interaction of the C-5 hydroxy group with the C-1
carboxyl.
Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes
Department of Pharmacology, University of Colorado Health Sciences Center, Denver 80262.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. A. Lawson, H. Li, J. Rokach, M. Adiyaman, S.-W. Hwang, S. P. Khanapure, and G. A. FitzGerald Identification of Two Major F2 Isoprostanes, 8,12-Iso- and 5-epi-8,12-Iso-isoprostane F2alpha -VI, in Human Urine J. Biol. Chem., November 6, 1998; 273(45): 29295 - 29301. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. DRAZEN Leukotrienes as Mediators of Airway Obstruction Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S193 - S200. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |